News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,085 Results
Type
Article (25952)
Company Profile (59)
Press Release (356074)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104403)
Career Advice (449)
Deals (16882)
Drug Delivery (51)
Drug Development (47654)
Employer Resources (47)
FDA (12267)
Job Trends (8449)
News (186119)
Policy (19427)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (73)
Alliances (26764)
ALS (57)
Alzheimer's disease (811)
Antibody-drug conjugate (ADC) (51)
Approvals (12331)
Artificial intelligence (170)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6896)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (192)
Cancer (1432)
Cardiovascular disease (119)
Career advice (407)
Career pathing (13)
CAR-T (70)
Cell therapy (199)
Cervical cancer (13)
Clinical research (40560)
Collaboration (440)
Compensation (126)
Complete response letters (9)
COVID-19 (1498)
CRISPR (12)
C-suite (139)
Cystic fibrosis (42)
Data (1525)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (174)
Diagnostics (3522)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (55)
Earnings (37002)
Editorial (20)
Employer branding (6)
Employer resources (44)
Events (51929)
Executive appointments (447)
FDA (13255)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (402)
Gene editing (36)
Generative AI (10)
Gene therapy (126)
GLP-1 (402)
Government (3036)
Grass and pollen (3)
Guidances (42)
Healthcare (12189)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (40)
Indications (19)
Infectious disease (1568)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (50)
Interviews (40)
IPO (7047)
IRA (19)
Job creations (1844)
Job search strategy (378)
Kidney cancer (7)
Labor market (10)
Layoffs (171)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (233)
Lymphoma (100)
Machine learning (3)
Management (17)
Manufacturing (104)
MASH (48)
Medical device (12906)
Medtech (12909)
Mergers & acquisitions (10124)
Metabolic disorders (432)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1144)
NextGen: Class of 2025 (3932)
Non-profit (2822)
Now hiring (16)
Obesity (218)
Opinion (70)
Ovarian cancer (52)
Pain (64)
Pancreatic cancer (53)
Parkinson's disease (88)
Partnered (11)
Patents (112)
Patient recruitment (82)
Peanut (37)
People (34749)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11620)
Phase II (17563)
Phase III (14428)
Pipeline (686)
Policy (59)
Postmarket research (1668)
Preclinical (3623)
Press Release (18)
Prostate cancer (76)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (184)
Real estate (2847)
Recruiting (16)
Regulatory (14214)
Reports (16)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (51)
Series A (66)
Series B (48)
Service/supplier (3)
Sickle cell disease (22)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2121)
Stomach cancer (8)
Supply chain (38)
Tariffs (11)
The Weekly (8)
Vaccines (354)
Venture capitalists (13)
Weight loss (141)
Women's health (17)
Worklife (4)
Date
Today (3)
Last 7 days (458)
Last 30 days (1357)
Last 365 days (18397)
2025 (5906)
2024 (19867)
2023 (22758)
2022 (30700)
2021 (33009)
2020 (32207)
2019 (28426)
2018 (21826)
2017 (18926)
2016 (18130)
2015 (21212)
2014 (16033)
2013 (13256)
2012 (14362)
2011 (14642)
2010 (13200)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (118)
Arkansas (10)
Asia (24554)
Australia (3887)
California (3064)
Canada (1221)
China (372)
Colorado (165)
Connecticut (172)
Delaware (115)
Europe (47938)
Florida (543)
Georgia (126)
Idaho (33)
Illinois (359)
India (14)
Indiana (223)
Iowa (3)
Japan (119)
Kansas (73)
Kentucky (12)
Louisiana (7)
Maine (27)
Maryland (634)
Massachusetts (2134)
Michigan (107)
Minnesota (270)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (33)
New Hampshire (60)
New Jersey (1125)
New Mexico (9)
New York (953)
North Carolina (554)
North Dakota (4)
Northern California (1345)
Ohio (131)
Oklahoma (3)
Oregon (23)
Pennsylvania (825)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (21)
Southern California (1171)
Tennessee (77)
Texas (538)
United States (12786)
Utah (111)
Virginia (80)
Washington D.C. (40)
Washington State (229)
West Virginia (3)
Wisconsin (42)
382,085 Results for "rigel medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
April 30, 2025
·
1 min read
Press Releases
Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
March 10, 2025
·
2 min read
Biotech Bay
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
Rigel Pharmaceuticals, Inc. (“Rigel”) (Nasdaq: RIGL) today announced the completion of the transfer to Rigel of the New Drug Application (NDA) for GAVRETO®.
June 24, 2024
·
10 min read
Press Releases
Rigel Provides Business Update and 2025 Outlook
January 14, 2025
·
14 min read
Press Releases
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 4, 2025
·
19 min read
Business
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Rigel Pharmaceuticals, Inc. announced the appointment of Lisa Rojkjaer, M.D. as Executive Vice President and Chief Medical Officer.
March 12, 2024
·
5 min read
Press Releases
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
February 26, 2025
·
1 min read
Press Releases
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
January 9, 2025
·
5 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
Press Releases
Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
1 of 38,209
Next
